Development of end stage renal disease following an acute cardiac event

Kidney International

Volumn 74, Issue 3, 2008, Pages 356-363

  Keough Ryan, Tammy M ^a   Kiberd, Bryce A ^a   Cox, Jafna L ^a   Thompson, Kara J ^a   Clase, Catherine M ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Acute coronary syndrome; Cardiovascular disease; Chronic kidney disease; Congestive heart failure; End stage kidney disease; Kidney disease

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR;

EID: 47349110864     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.190     Document Type: Article

References (31)

1. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease. A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 2003; 108: 2154-2169.
2. Parfrey PS. Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. IV. Recommendations for the management of cardiovascular risk factors. Nephrol Dial Transplant 2000; 15(Suppl 5): S58-S68.
3. Smith GL, Lichtman JH, Bracken MB et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 2006; 47: 1987-1996.
4. Keough-Ryan TM, Kiberd BA, Dipchand CS et al. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia. Am J Kidney Dis 2005; 46: 845-855.
5. Langston RD, Presley R, Flanders WD et al. Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction. Kidney Int 2003; 64: 1398-1405.
6. Shlipak MG, Heidenreich PA, Noguchi H et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137: 555-562.
7. Wright RS, Reeder GS, Herzog CA et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann Intern Med 2002; 137: 563-570.
8. Walsh CR, O'Donnell CJ, Camargo CA et al. Elevated serum creatinine is associated with 1-year mortality after myocardial infarction. Am Heart J 2002; 144: 1003-1011.
9. Al Suwaidi J, Reddan DN, Williams K et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974-980.
10. McClellan WM, Langston RD, Presley R. Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. J Am Soc Nephrol 2004; 15: 1912-1919.
11. Eriksen BO, Ingebretson OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-382.
12. Evans M, Fryzek JP, Elinder C-G et al. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. Am J Kidney Dis 2005; 46: 863-870.
13. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850.
14. McClellan WM. Epidemiology and risk factors for chronic kidney disease. Med Clin N Am 2005; 89: 419-445.
15. Cody J, Daly C, Campbell M et al. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients. Cochrane Database Syst Rev 2005; 3: CD003266.
16. Clase CM, Garg AX, Kiberd BA. Classifying kidney problems: can we avoid framing risks as diseases? Br Med J 2004; 329: 912-915.
17. Levey AS, Eckardt K-U, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100.
18. Patel UD, Young EW, Ojo AO et al. CKD progression and mortality among older patients with diabetes. Am J Kidney Dis 2005; 46: 406-414.
19. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663.
20. Go SA, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular disease events, and hospitalization. N Eng J Med 2004; 351: 1296-1305.
21. Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. Br Med J 2006; 333: 1047-1050.
22. Foley RN, Murray AM, Li S et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489-495.
23. MacKinnon M, Leenen FH, Ruzicka M. Does ALLHAT change the management of hypertension in chronic kidney disease? Curr Hypertens Rep 2005; 7: 474-483.
24. Rahman M, Pressel S, Davis BR et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic. Arch Intern Med 2005; 165: 936-946.
25. Rahman M, Pressel S, Davis BR et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by glomerular filtration rate. Ann Intern Med 2006; 144: 172-180.
26. Weiner DE, Tabatabai S, Tighiouart H et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 2006; 48: 392-401.
27. Wattanakit K, Coresh J, Muntner P et al. Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction. J Am Coll Cardiol 2006; 48: 1183-1189.
28. Tonelli M. Should CKD be a coronary heart disease equivalent? Am J Kidney Dis 2007; 49: 8-11.
29. Cox JL On behalf of the ICONS Investigators. Optimizing disease management at a health care system level: the rationale and methods of the improving cardiovascular outcomes in Nova Scotia (ICONS) study. Can J Cardiol 1999; 15: 787-796.
30. Levey AS, Greene T, Kusek JW et al. MDRD study group: a simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: A0828.
31. Couchoud C, Pozet N, Labeeuw M et al. Screening early renal failure: cut off values for serum creatinine as an indicator of renal impairment. Kidney Int 1999; 55: 1878-1884.